INVESTIGATION OF TLR4 POLYMORPHISM IN CHILDREN WITH VESICOURETERAL REFLUX AND RENAL SCARRING
Sav NM1*, Eroz R2, Kalay Duran N3, Kilicaslan O4, Erisen Karaca S5
*Corresponding Author: *Corresponding Author: Nadide Melike SAV, Address: Duzce Universitesi Araştırma Uygulama Hastanesi, Pediatrik Nefroloji B.D, Merkez, DUZCE, TURKEY; Phone: +905378683281; Fax:+903805421390; e-mail address: savmelike@gmail.com
page: 41

MATERIALS AND METHOD

This cross-sectional study was carried out with 49 patients who were followed up due to primary vesico- ureteral reflux at Duzce University, Faculty of Medicine, Department of Pediatric Nephrology, Duzce, Turkey. Patients under 18 years of age with VUR and recur- rent UTIs were included in the study. Oral and written informed consent was obtained from all individual partici- pants and their families included in the study. Those who did not give consent and those who had additional renal or other system anomalies and patients with stage 5 CKD were excluded. The study protocol was approved by the Institutional Ethics Committee of Duzce University School of Medicine (Ethics No: 2019/285). The study was con- ducted by the ethical principles set forth in the Declaration of Helsinki. This project was supported by the Scientific Research Project Department of Duzce University (Grant number: 2021.04.03.1194). Diagnosis of UTI was made based on history and exam findings and confirmed with appropriately collect- ed urine. The presence of VUR was confirmed by voiding cystourethrography (VCUG) and the severity of VUR was graded according to the International Reflux Study in Children (IRSC) (I-V) [7]. A DMSA scan was performed 6 months after the last UTI. Patients were divided into two groups according to the presence of any kidney scars determined in the DMSA scan. Office blood pressure was measured by the auscultation method. Before start- ing blood pressure measurements, the patient rested in a sitting position for at least 3-5 minutes, relaxed and rested. The arm was outstretched, in line with the mid-sternum and supported. An appropriately sized cuff was wrapped around the upper arm and connected to a manometer and blood pressure was measured. Genomic DNA was isolated from 200 μl peripheral leukocytes of the cases using DNA isolation kits (Anatolia Diagnostics and Biotechnology Products Inc., Istanbul, Turkey). Polymerase chain reaction (PCR) pools generated before the NGS reaction were purified by the NucleoFast 96 PCR (MACHEREY-NAGEL GmbH) kit. Then the quantification of the PCR products was standardized on NanoDrop 1000 (Thermo Fisher Scientific Inc.) and the TLR4 gene was sequenced by NGS (MISEQ-Illumina). Se- rum and urine biochemical parameters were also recorded. Statistical Analysis The data were analyzed via IBM SPSS Statistics 22.0 (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.). The Shapiro-Wilk test was performed to examine the distribu- tion of data. All quantitative variables were reported by mean±standard deviation (SD) and median (interquartile range: IQR), as categorical variables were summarized by frequency and %. The Mann-Whitney U test was per- formed to compare the patients with and without scares with respect to the quantitative variables. Pearson chi- square test, Fisher’s exact test and Fisher-Freeman-Halton test were used to reveal the differences between two groups for categorical variables. A p-value≤0.05 was considered statistically significant.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006